Related Experiment Video
Updated: Mar 28, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
An Initiative to Improve Clozapine Prescribing in New York State
Jay Carruthers1, Marleen Radigan1, Matthew D Erlich1
1Dr. Carruthers, Dr. Radigan, Dr. Erlich, Mr. Gu, Mr. Wang, Dr. Frimpong, Dr. Miller, and Dr. Sederer are with the New York State Office of Mental Health, Albany (e-mail: jay.carruthers@omh.ny.gov ). Dr. Carruthers is also with the Department of Psychiatry, Albany Medical College, Albany, New York. Dr. Radigan and Dr. Erlich are also with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York City, where Dr. Essock and Dr. Stroup are affiliated. Dr. Sederer is also with the Mailman School of Public Health, Columbia University, New York City. Dr. Essock and Dr. Stroup are also with the New York State Psychiatric Institute, New York City, where Dr. Olfson is affiliated. Dr. Olfson is also with Columbia University Medical Center, New York City. Dr. Castillo is with the Robert Wood Johnson Foundation Clinical Scholars Program, University of California, Los Angeles. Marcela Horvitz-Lennon, M.D., M.P.H., is editor of this column.
Abstract:
Clozapine remains the only medication approved for treatment-resistant schizophrenia. But underuse is the norm. In 2010, the New York State Office of Mental Health began a multifaceted initiative to promote the evidence-based use of clozapine. From 2009 to 2013, in the absence of a well-funded pharmaceutical marketing campaign, the proportion of new clozapine trials among all new outpatient antipsychotic trials increased 40% among adult New York Medicaid recipients with a diagnosis of schizophrenia. The largest gains occurred in state-operated clinics. New York's experience demonstrates the feasibility of making clozapine more accessible to patients who stand to benefit most.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

